2026 NPPES data Neurocritical Care Physician NPI 1205577681 MD, PHD
Verify on CMS →

Robert Kim, MD, PHD

Neurocritical Care Physician in West Hollywood, California.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 389 in Neurocritical Care Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
40
Medicare Part D claims · Neurocritical Care Physician avg: 291
Generic prescribing
65%
generic claims · 35% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

Robert Kim, MD, PHD filed 40 Medicare Part D claims in 2024 as a Neurocritical Care Physician in West Hollywood, California, prescribing 65% generic.

40
Part D claims, 2024
65%
generic prescribing
≥0th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Robert Kim, MD, PHD

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1205577681), first enumerated 04/07/2022.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 40 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.

    Source: NUCC taxonomy + CMS participation heuristic

  • State context

    State board disciplinary context

    California statewide board action statistics are published annually — these figures describe aggregate state activity, not Robert Kim, MD, PHD's individual license status. Verify directly with the state medical board.

    Source: MBC annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1205577681 · Neurocritical Care Physician

NPI-10 · ENUM-RECENT · TAX-TRACE · RX-TRACE · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1205577681
  • ENUM-RECENT 2022
  • TAX-TRACE 389
  • RX-TRACE 40
  • BOOK-THIN 41 in California
  • PHOTO-ENUM Syed Hussain · 2022

Robert Kim, MD, PHD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

40 ≥ 0th percentile 0% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). This entry sits in this band. 200–400: 188,835 prescribers (13%). Above this entry. 400–600: 95,866 prescribers (7%). Above this entry. 600–800: 60,107 prescribers (4%). Above this entry. 800–1,000: 43,043 prescribers (3%). Above this entry. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board-eligible specialty (heuristic, not verified)

Robert Kim, MD, PHD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Robert Kim, MD, PHD?

Quality data not reported

NPI registry status

Active

Issued 04/07/2022

NPI 1205577681

Primary specialty

Neurocritical Care Physician

Rare

389 US NPIs in this specialty

Medicare Part D claims

40 86% vs specialty avg

2024 prescription claims

Specialty avg: 291

Specialty distribution in California

How Neurocritical Care Physician compares to other specialties among California providers

California providers
Behavior Technician17.9%Marriage & Family Therapist5.4%Student in an Organized Heal…5.1%Mental Health Counselor3.7%Pharmacist3.4%Clinical Social Worker3.1%Neurocritical Care Physician0%
Largest specialties in California (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Neurocritical Care Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

8700 BEVERLY BLVD # 2900A
West Hollywood, CA 90048

Provider Details

NPI 1205577681
Specialty Neurocritical Care Physician
Credentials MD, PHD
Gender Male
NPI Issued 04/07/2022

License & disciplinary context - California MBC 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Robert Kim, MD, PHD. To verify Robert Kim, MD, PHD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Robert Kim, MD, PHD - brand share 35.0%
Neurocritical Care Physician average

35% brand-name claims vs 65% generic, on 40 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

40
Total Claims
$11K
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
59.167
Total Day Supply
1,702
Brand vs Generic
35% brand / 65% generic
Brand Drug Cost
$10K
Generic Drug Cost
$610

Patient Demographics

Average Patient Age
70.2 years
Avg HCC Risk Score
2.10

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

Drug Claims
Emgality Pen
Galcanezumab-Gnlm
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neurocritical Care Physician Overview

How Robert Kim, MD, PHD fits within the Neurocritical Care Physician landscape nationally.

389
Neurocritical Care Physician Providers in US
45
States with Neurocritical Care Physician
291
Avg Claims per Provider

Robert Kim, MD, PHD's 40 claims are below the specialty average of 291.

Nationwide Neurocritical Care Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Kim, both outside California so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2022)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Neurocritical Care Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Kim.

One of 41 Neurocritical Care Physician providers enrolled in California, 5 are shown here.

Compare Neurocritical Care Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Robert Kim, MD, PHD's specialty?
Robert Kim, MD, PHD specializes in Neurocritical Care Physician and practices in West Hollywood, California. Credentials: MD, PHD.
How much does Robert Kim, MD, PHD prescribe under Medicare Part D?
In 2024, Robert Kim, MD, PHD wrote 40 Medicare Part D claims totaling $11K in drug costs for N/A beneficiaries.
Where is Robert Kim, MD, PHD located?
Robert Kim, MD, PHD is located at 8700 BEVERLY BLVD # 2900A, West Hollywood, CA, 90048. Phone: (310) 423-3277.
What is Robert Kim, MD, PHD's NPI number?
Robert Kim, MD, PHD's National Provider Identifier (NPI) is 1205577681, issued on 04/07/2022.
Does Robert Kim, MD, PHD prescribe more brand-name or generic drugs?
Robert Kim, MD, PHD's prescribing is 35% brand-name and 65% generic drugs by claim count, with $10K in brand drug costs.
How many Neurocritical Care Physician providers are there in the US?
There are 389 Neurocritical Care Physician providers across 45 states in the US. The average Neurocritical Care Physician provider writes 291 Medicare Part D claims per year.
What drugs does Robert Kim, MD, PHD prescribe most often?
Based on 2024 Medicare Part D data, Robert Kim, MD, PHD's most frequently prescribed drugs include Emgality Pen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Robert Kim, MD, PHD accept Medicare?
Robert Kim, MD, PHD appears in CMS Medicare data with 40 Part D claims and N/A Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Robert Kim, MD, PHD's credentials?
Robert Kim, MD, PHD's NPI is 1205577681 with credentials MD, PHD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.